Concepedia

Kristin McLarty

KM

Statistics

Publications

13

Citations

601

H-Index

12

Active since

2007

Affiliations

University of Toronto(Current)

University Health Network

University of Oxford

Ontario Institute for Cancer Research

Hospital for Sick Children

Kristin McLarty is an author at University of Toronto specializing in medicine, radiation oncology, and tumor biology.

Top concepts

Publications per year

2007–2013

13

Publications

13

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts

Kristin McLarty, Bart Cornelissen, Deborah A. Scollard et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 126 citations

, , +10

Trastuzumab-Resistant Breast Cancer Cells Remain Sensitive to the Auger Electron–Emitting Radiotherapeutic Agent <sup>111</sup>In-NLS-Trastuzumab and Are Radiosensitized by Methotrexate

Danny L. Costantini, Katherine Bateman, Kristin McLarty et al. · Journal of Nuclear Medicine · 2008 · 87 citations · Full text

Micro-SPECT/CT with <sup>111</sup>In-DTPA-Pertuzumab Sensitively Detects Trastuzumab-Mediated <i>HER2</i> Downregulation and Tumor Response in Athymic Mice Bearing MDA-MB-361 Human Breast Cancer Xenografts

Kristin McLarty, Bart Cornelissen, Zhongli Cai et al. · Journal of Nuclear Medicine · 2009 · 75 citations · Full text

Antitumor Effects and Normal-Tissue Toxicity of <sup>111</sup>In-Nuclear Localization Sequence-Trastuzumab in Athymic Mice Bearing <i>HER</i>-Positive Human Breast Cancer Xenografts

Danny L. Costantini, Kristin McLarty, Helen Lee et al. · Journal of Nuclear Medicine · 2010 · 75 citations · Full text

Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells

Bart Cornelissen, Meiduo Hu, Kristin McLarty et al. · Nuclear Medicine and Biology · 2007 · 45 citations

, , +8

1–5 of 13